Results DHT treatment significantly decreased KGN cell viability, MMP and ATP levels, increased LDH release, ROS, MDA, iron ions and LPO content, up-regulated Cytochrome C expression, and down-regulated Ferritin, TFAM, and GPX4 expression
Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent
17 17 18 18 18 demonstrated that 8 weeks with a dose of 90 g/day of menaquinone-7 (vitamin K2) reduced waist circumference, fasting insulin, HOMA-IR, triglycerides, DHT, SHBG, and HOMA- while increasing the QUICKI index, compared to placebo
Vargas, H.O
The FLOW trial of semaglutide versus placebo for kidney outcomes was stopped early due to evidence of kidney protection
NHS support for home administration: Most GP practices offer training sessions where practice nurses demonstrate proper injection technique, sharps disposal, and emergency procedures